TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.
Authors:
- D Kandioler-EckersbergerDKD Kandioler-Eckersberger
- C LudwigCLC Ludwig
- M RudasMRM Rudas
- S KappelSKS Kappel
- E JanschekEJE Janschek
- C WenzelCWC Wenzel
- H Schlagbauer-WadlHSH Schlagbauer-Wadl
- M MittlböckMMM Mittlböck
- M GnantM Gnant
- G StegerGSG Steger
- R JakeszRJR Jakesz
- 1 January 2000
- journal article
- clinical trial
- Vol. 6 (1) , 50-6